Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Viramidine to enter phase II trials in hepatitis C

Nov. 6, 2002

Renzapride reduces GI transit time, increases colonic motility in IBS patients and healthy subjects

Nov. 6, 2002

Incara divests liver cell program

Nov. 6, 2002

Beneficial effects of Z-338 in patients with functional dyspepsia

Nov. 4, 2002

Rectal administration of PL-14736 safe in first human study

Nov. 4, 2002

YH-1885 for one week significantly inhibits intragastric acidity in humans

Nov. 4, 2002

Effects of Enteryx on LES function in GERD patients

Nov. 4, 2002

New class of CpG oligonucleotides with promise for HCV infection

Oct. 31, 2002

Potent and gut-selective Ca2+ channel antagonist with potential in IBS

Oct. 30, 2002

Jerini initiates phase I trial of icatibant for decompensated liver cirrhosis

Oct. 29, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...